Holly Campbell

Head of External Communications @FoundationATCG. Passionate about health care and rescue dogs.

[Josh Shultz @joshshultz]

My kids are huge fans of @Mike_kim714 — not just because he stripe irons and grinds every week, but because he’s humble, funny, and actually teaches people something about golf. Hard to find athletes who make the game feel more accessible. Appreciate you, Michael.

[Stephen J. Ubl @steveubl]

In honor of #WomensHistoryMonth, I asked women across our leadership team to share their experiences and advice with the next generation. Here’s my interview with @lreilly71, @PhRMA's first COO. https://t.co/TZgVuKr9An

[Stephen J. Ubl @steveubl]

Our industry is collaborating with regulators and health care orgs worldwide to develop solutions to diagnose and treat #Coronavirus. More than half of @PhRMA members have R&D efforts underway or are donating medicines/medical supplies/financial support. https://t.co/s6pJthmpmQ

[PhRMA @PhRMA]

37% of biopharma industry jobs are in STEM occupations – more than 6x the private sector average. Learn more.

[Stephen J. Ubl @steveubl]

Excited to have our @Roadmap2Health team on-site today. This bilingual, mobile health fair travels around the country, offering health screenings for cholesterol, blood pressure, and BMI. This is just one way we're working to remove barriers to care.

[PhRMA @PhRMA]

.@FoxBusiness: Big pharma seeks to change its reputation amid drug pricing crackdown. https://t.co/rwzdu8fZUJ @steveubl: One of the things I really wanted to bring to the organization is a more proactive approach where we are bringing pragmatic, pro-consumer policies to the table

[Stephen J. Ubl @steveubl]

Since joining @PhRMA, I’ve been focused on bringing pragmatic, pro-consumer policies to the table. Many of these ideas were discussed in today’s @SenFinance hearing on #drugprices. Specifically we have advocated for the following ideas: 1/8

[Stephen J. Ubl @steveubl]

I laud @POTUS’ goal of ending #HIV infections within 10 years. America is a land of innovators & our biopharmaceutical scientists & researchers are working tirelessly to make this goal a reality. #SOTU

[Dr. Mike @mybarra]

@phrma reports that 289 gene therapies in development. After a decade in the ER, exciting for me to think about treatments on the horizon for #sicklecell, #cancer, #hemophilia, other serious diseases. Read my quotes in the link. #GoBOLDLY https://t.co/GaAZ8j6Coa

[Stephen J. Ubl @steveubl]

59 new treatments were approved by the @US_FDA in 2018 - the majority of them (42) were first approved in the United States. When biopharmaceutical companies are encouraged to innovate, American patients benefit. Read more by @AndrewPowaleny. https://t.co/BvCp8Y2mdu

[Stephen J. Ubl @steveubl]

Great read from @CGrantWSJ highlighting that drug price trends have moderated & "retail drug spending grew by just 0.4% in 2017 according to @CMSGov data. Larger categories of health spending, such as hospitals or doctor’s offices, grew closer to 4%." https://t.co/VSjaBzGvwc

[PhRMA @PhRMA]

6 facts you need to know about the insulin market. ”Unfortunately, patients typically do not benefit from the competitive marketplace b/c the price they pay at the pharmacy – set by their insurer – is tied to the undiscounted list price.” Read more: https://t.co/7hPWjlDV0E

[Stephen J. Ubl @steveubl]

According to @CMSGov, spending on retail medicines grew by just 0.4 percent last year, substantially less than hospital spending growth (4.6%) and physician & clinical services spending (4.2%). This is the slowest growth rate since 2012. https://t.co/zIiKuc9q4b

[PhRMA @PhRMA]

New report shows nearly 300 cell and gene therapies in development https://t.co/VdcXXDixvh #GoBOLDLY

[Stephen J. Ubl @steveubl]

A must read from @StephenMoore in @NRO. Agree there are right ways & wrong ways to address patient affordability challenges. Imposing foreign pricing schemes on seniors in Part B is the wrong approach. https://t.co/yjunkbNoCs

[Stephen J. Ubl @steveubl]

Read @phillydotcom’s profile of @Merck CEO Ken Frazier. There’s no better principled, inspiring leader in Philadelphia to be chosen as Inquirer Business Hall of Fame Icon. Congratulations on your hard work and success, Ken. https://t.co/mh5nbzljZp

[Stephen J. Ubl @steveubl]

We are not for the status quo. We’ve come to the table w/ market-based reforms & one area we agree is testing value-based models that align reimbursement w/ patient outcomes. Foreign price controls takes our health care system in the opposite direction. https://t.co/GO9vblFh6I

[PhRMA @PhRMA]

Leadership at PhRMA member companies agree that the industry’s new approach to DTC television advertising is an important step toward creating a health care system that works better for patients. Here’s what they said: https://t.co/zFnsqyFa5w

[PhRMA @PhRMA]

#HUBweek attendees, here’s the report we released this week - “Strengthening Biopharmaceutical Innovation: The Growing Role of Corporate Venture Capital” https://t.co/8P93K94k9F #hubweek #HUBweek2018 #PhRMA #corporateventurecapital #vc @TEConomyP_LLC @HUBweek

[PhRMA @PhRMA]

As one of the world’s top research hubs driving today’s new era of medicine, Boston is known globally as an example of an ecosystem built for innovation. But innovation doesn’t just happen. Anne McDonald Pritchett, Ph.D. weighs in for #HUBweek https://t.co/cOOz4JWpyo @HUBweek